Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, reflecting a minor update to the site's framework rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T20:30:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.5, indicating a new version of the ClinicalTrials.gov record. This reflects a minor administrative update to the page rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T11:06:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The site's revision label was updated from v3.6.3 to v3.6.4, representing a new build of the page without changing its content or behavior.
    Difference
    0.1%
    Check dated 2026-07-25T06:19:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.2 to v3.6.3, signaling a minor behind-the-scenes update.
    Difference
    0.1%
    Check dated 2026-07-03T20:09:32.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.0 to v3.6.2. This reflects a minor backend or rendering update.
    Difference
    0.1%
    Check dated 2026-06-26T20:20:31.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Adds the investigator’s name and new navigation headings, and removes older phrasing and revision notes, reflecting updates to the page’s metadata and user guidance.
    Difference
    2%
    Check dated 2026-06-12T12:46:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.